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Discordant clinical phenotypes of siblings with identical CFTR mutations and the 
large variability of clinical manifestations of patients who are homozygous for 
the most common mutation F508del suggest hat both environment and genes 
other than CFTR contribute substantially to CF disease. Candidates for genetic 
modifiers in CF are elements of host defence, such as the TNFo, receptor, and 
of ion transport, such as the amiloride-sensitive epithelial sodium channel ENaC, 
both of which are encoded side by side on 12p13 (TNFRSF1A, SCNN1A) and 
1@12 (SCNN1B, SCNN1G). Thirty-seven families with F508del-CFTR hornozy- 
gous siblings exhibiting extreme clinical phenotypes from the European CF Twin 
and Sibling Study [1] were genotyped at 12p13 and 1@12 markers. The ENaC 
was identified as a modulator of CF by transmission disequilibrium at SCNN1G 
and association with CF intrapair discordance at SCNN1B [2]. Family-based and 
case~ontrol analyses and sequencing of SCNN1A and TNFRSF1A uncovered an 
association of the TNFRSF1A intron 1 haplotype with disease severity [2]. Carriers 
of risk haplotypes were underrepresented, suggesting a strong impact of both loci 
on survival. The finding that TNFRSF1A, SCNN1B and SCNN1G are clinically 
relevant modulators of CF disease supports current concepts that the depletion of 
airway surface liquid and inadequate host inflammatory esponses trigger pulmonary 
disease in CE 
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Background: Polymorphisms in cytokine genes can influence inflammation and 
tissue damage and, consequently, may affect disease progression in cystic fibro- 
sis (CF), a multiorgan disorder characterized by an altered inflammatory esponse. 
Methods: We analyzed single-nucleotide polymorphisms in the genes for tumor 
necrosis factor-f3 (TNF-f3)? at position +252A/G and TNF-o, at positions 857C/T 
and 308G/A in a population of 381 young patients with CE Genotypes were tested 
for an association with changes in lung function tests, infection with Pseudomonas 
aeruginosa nd nutritional status by multivariable analysis. 
Results: Haplotype analysis revealed that the most frequent haplotype 
TNF-f3 +252A/TNF-o, 857C/TNF-o, 308G was associated with a significantly 
slower decline in both forced expiratory volume in one second and forced vital 
capacity (p 0.01, respectively). 
Conclusion: The TNF-f3 +252A/TNF-~, 857C/TNF-~, 308G haplotype is a 
marker of less rapid deterioration of lung function in children with CE 
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F508del homozygous CF patients differ widely in disease manifestation, suggesting 
that environmental f ctors and genes other than CFTR significantly influence course 
and prognosis. Since the basic defect manifests in defective epithelial chloride 
transport, alternative chloride conductances have been suggested topartially account 
for the heterogeneity of clinical disease. The CLCA locus encoding 4 homologous 
proteins has been shown to influence non-CFTR mediated chloride conductance in
intestinal epithelium and hence is a promising candidate for a modulator of the basic 
defect in CF [1]. We wanted to identify the gene sequences within the locus that are 
associated with the expression of this non-CFTR mediated chloride conductance. 
Our study population of predominantly AF508 homozygous individuals from the 
European Twin and Sibling study consists of 25 two-generation families with 32 
CF patients. Their electrophysiological phenotype resolved by intestinal current 
measurement of rectal suction biopsies was differentiated into one group without 
any residual chloride conductance (n 21) and another group with DIDS-sensitive 
alternative chloride conductance (n 11). Eleven informative SNPs spanning the 
whole CLCA locus of about 210kbp were employed to compare the distribution 
of 2-marker haplotypes in the two cohorts with contrasting chloride conductance 
phenotypes. The localization of the putative modulator within the CLCA-gene 
cluster was narrowed by haplotype mapping to a 30 kbp fragment that is currently 
being refined by sequencing of contrasting haplotypes. 
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Cystic fibrosis is caused by mutations in the Cystic Fibrosis Transmembrane Con- 
ductance Regulator gene (CFTR). An abnormal CFTR affects the epithelials cells 
of many organs uch as the airways, pancreas, liver, etc. The clinical expression of 
the disease is heterogeneous. Only approximately 8% of patients have liver disease. 
Because cystic fibrosis patients bearing the same CFTR genotype can express a 
very different liver phenotype, studies on modifier gene have emerged. At this date, 
many genes primarily involved in the cycle of inflammation have been identified as 
potential modifiers. 
The aim of our study is to assess the role of the two novel candidate genes, the 
Keratin 8 (K8) and Keratin 18 (K18) genes, as potential liver risk factors in cystic 
fibrosis. Mutations in these genes have been reported to present risk factors in 
other multiple liver diseases like chronic hepatitis. Moreover, a recent study has 
shown that cells transfected by AF508-CFTR expressed more K8 and K18 than 
cells transfected by the wild-type CFTR. 
For this study, samples from 27 CF patients uffering from severe liver disorders 
have been analysed. The coding regions of K8 and K18 genes were sequenced 
for these 27 CF patients. Only several polyrnorphisms have been found in the 
two candidate genes. In K18, a variant p.S229T described as a polymorphism was 
found in one patient. In K8, an association between two new variations p.R341H 
and g.1320+1 ldelC has been identified in 2 of 27 patients and in 3 controls DNA. 
By this study, no relation between liver disease in CF patients and mutations in K8 
and K18 genes has been established. 
